Semi-Solid Dosage Form Market

Semi-Solid Dosage Form Market - Global Assessment 2021 - 2031, Industry Analysis and Opportunity

Semi-Solid Dosage Form Market

Semi-Solid Dosage Form Market Forecast

According to the latest research by Persistence Market Research, the Semi-Solid Dosage Form Market is set to witness growth during 2021-2031. There has been increase in prevalence of skin diseases worldwide owing to the factors from global warming to dermal reactions due to use of medications.

The main problem with topical semi-solid drug dosage form was that its side effects varied from person to person. Research studies which are being carried out to oust this issue will definitely push this market forward.

Also, this dosage form is beginning to rise as an answer to certain ailments whose original treatments were proving to be painful to the care receiver. This is another important factor that will definitely impact the market in a very positive way.

Find Out More about the Report Coverage

What are the Major Drivers for Semi-Solid Dosage Form Market?

Semi-solid dosage forms contain both solid as well as liquid which makes them viscous in nature. They are used for therapeutic and cosmetics functions in a topical or superficial way. The main drivers for this market is the site-specific action of the administered drug as the mechanism of healing will only take place at the site where it is applied.

The fact the these dosage forms reduce the risk of loss of the drug’s potency due the human body’s first-pass metabolism is a major driver for this market.

Oral drugs can have a drawback of leaving a bitter after test as well as bioavailability at the site of requirement. This issue is resolved by semi-solid drugs as hepatic metabolism along with the topical nature which will prove to be better alternative for bitter drugs. These factor will definitely play a crucial role in driving the market forward.

However, this dosage has some drawbacks that might restrain this market from growing at a desired rate. Semi-solid dosages sometimes tend to cause irritations as well as allergies at the site. Regardless with researches being conducted to improve on the already existing drug delivery systems, researches can find ways to work around these restraints.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Development of Ointment for Cutaneous Leishmaniasis

According to the MDPI published in 2019, a case study conducted by researchers of Spain, if a semi-solid dosage form can be developed for the parasitic infection of Cutaneous Leishmaniasis (CL). CL is widely treated with intralesional injection which can prove to be painful for some.

So, these researchers aimed to develop an alternative ointment which used gel-based formulation of drug called as Megalumine antimoniate (MA) which is normally used in the intralesional injection for treating CL. The stability, permeation level and other physicochemical properties were then studied.

They at the end concluded that, this ointment proved to be having higher acceptance in the patients. Also having low permeability into the skin results in low drugs level in the blood which ultimately reduces the toxicity of the ointment. These results certainly put up a competitive alternative for the injection used in CL treatment.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

The US and Canada Demand Outlook for Semi-Solid Dosage Form Market –

U.S. is the most dominant market player in the North American region. Prominent reason for this is adequate amount of government financial support which encouraged researchers’ constantly finding novel ways to use a specific drug form in variety of different ways.

American Academy of Dermatology recently published statistics stating that, skin diseases alone cost U.S. healthcare system US$ 75 billion dollar yearly. Also, 1 in 4 American citizen is impacted by some or the other kind of skin disease. Rise in incidence of skin ailments is also boosting this market in the regional market.

Explore Persistence Market Research’s expertise in promulgation of the business !

Europe Demand Outlook for Semi-Solid Dosage Form Market –

About one third of the world’s population is affected by some or the other kind of skin disease, making it the world’s fourth most common cause of diseases caused in humans.

A 2018 study published by British Association of Dermatologists conducted investigation in adults from 5 European countries said that prevalence of skin diseases was seen higher in the Northern Europe in countries like Germany, Netherlands in comparison with the Southern European countries like Italy, Portugal.

Cost-effective as well as novel formulations and increase in disease prevalence due to heredity, Europe has emerged as second most profitable market after U.S. With increase in prevalence of various type of skin diseases, research in development of drugs that with higher efficiency are rapidly increasing; opening up novel avenues in the market.

Who are the Key manufacturers in Semi-Solid Dosage Form Market?

Key manufacturers in Semi-Solid Dosage Form Market include:

  • Johnson & Johnson
  • Merck & Co
  • Bayer AG
  • Hisamitsu Pharmaceutical
  • Glenmark Pharmaceuticals
  • Cipla Ltd
  • Nestlé SA
  • Novartis AG
  • GlaxoSmithKline plc
  • Bausch Health Companies
  • Allergan plc
  • Biofrontera, Inc.
  • Crown Laboratories Inc.
  • Akorn Inc. (US)
  • Ingenus Pharmaceuticals
  • Sun Pharmaceuticals
  • Crescita Therapeutics Inc.
  • Mylan N.V.
  • Encore Dermatology, Inc.
  • LEO Pharma
  • Almirall, S.A
  • Aclaris Therapeutics, Inc.
  • Taro Pharmaceutical Industries Ltd.
  • Teligent Pharma
  • Perrigo Pharma

Key Segments

By Product Type:

  • Ointments
  • Pastes
  • Cream
  • Plasters
  • Gels
  • Rigid Foams

By Application:

  • Skin
  • Nasal Cavity
  • Vaginal Cavity
  • Rectal Cavity
  • Others

By Ingredient Type:

  • Bases
  • Preservative
  • Humectants
  • Antioxidants
  • Emulsifier
  • Gelling agent
  • Permeation enhancer
  • Buffers

By End User:

  • OTC
    • Drug Stores
    • Online Retailers
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Semi-Solid Dosage Form Market Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Recommendations

Emergency Contraceptive Pills Market

Global Emergency contraceptive pills market to reach US$ 1,230 million, and is expected to exhibit sluggish growth and reflect less than 3% CAGR during 2017-2022.

Opioids Market

The global opioids market is expected to expand at a moderate CAGR of over 3% over the next ten years, and be valued at more than US$ 57 Bn by 2031-end.

Atrophic Scar Treatment Market

Over the forecast period 2017-2025, the global market for atrophic scar treatment will reportedly grow at a CAGR of 4.6% along with a healthy revenue. More details.

Postoperative Pain Management Market

The global postoperative pain management market is expected to be worth US$ 45,861.8 Mn in 2026, it is projected to increase at a CAGR of 5.1% through 2026..

Our Clients

Our Clients